These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 4917376)

  • 1. [Significance and clinico-experimental value on study methods of fetal erythroblastosis. 3. Determination of blood-group antigens by means of the immunofluorescence technic in special experimental and clinical conditions].
    Spoto P; Senesi S; Campa M; Palagi R
    Minerva Ginecol; 1970 Jun; 22(11):549-55. PubMed ID: 4917376
    [No Abstract]   [Full Text] [Related]  

  • 2. [Significance and clinico-experimental value of study methods of fetal erythroblastosis. IV. Immunological findings in organs of newborns affected by neonatal erythroblastosis].
    Palagi R; Giorgi G; Spoto P
    Minerva Ginecol; 1970 Jun; 22(11):556-65. PubMed ID: 4917377
    [No Abstract]   [Full Text] [Related]  

  • 3. [Significance and clinico-experimental value of the methods of study of hemolytic disease of the newborn. II. Labeling of blood group antibodies with fluorescein isothiocyanate].
    Spoto P; Campa M; Palagi R; Senesi S
    Minerva Ginecol; 1970 May; 22(10):496-9. PubMed ID: 4929592
    [No Abstract]   [Full Text] [Related]  

  • 4. Genetics in medicine: a review. Immunogenetics. Genetics of immunological deficiency states.
    Clarke CA; Evans DA; Harris R; McConnell RB; Woodrow JC
    Q J Med; 1968 Apr; 37(146):220-41. PubMed ID: 4968507
    [No Abstract]   [Full Text] [Related]  

  • 5. [Study of the antigenicity of factors A and B in the newborn].
    Ducos J; Ohayon E; Marty Y
    Rev Fr Transfus; 1969; 12(1):Suppl:37-43. PubMed ID: 5393863
    [No Abstract]   [Full Text] [Related]  

  • 6. [Prophylaxis of hemolytic disease of newborn].
    Kietlińska-Kmiolek Z
    Wiad Lek; 1971 Apr; 24(8):755-60. PubMed ID: 4996047
    [No Abstract]   [Full Text] [Related]  

  • 7. [Serology of ABO erythroblastosis].
    Speiser P
    Wien Med Wochenschr; 1966 Nov; 116(46):974-5. PubMed ID: 5989480
    [No Abstract]   [Full Text] [Related]  

  • 8. [On the prevention of Rh immunization in Sweden].
    Bartsch FK; Bergman PO; Bååthe P; Dahlen-Nilsson I; Hansson LA; Ryttinger LA
    Bibl Haematol; 1969; 32():135-40. PubMed ID: 4980799
    [No Abstract]   [Full Text] [Related]  

  • 9. [Editorial: Immunologic approach to the maternal-fetal relation].
    Dosne Pasqualini C
    Medicina (B Aires); 1974; 34(6):667-9. PubMed ID: 4459666
    [No Abstract]   [Full Text] [Related]  

  • 10. [Errors and disagreements in the determination of factor RhO (D)].
    Ducos J; Ruffié J; Marty Y
    Rev Fr Transfus; 1969; 12(1):Suppl:81-91. PubMed ID: 4987787
    [No Abstract]   [Full Text] [Related]  

  • 11. [ISOANTIGENIC PROPERTIES OF TYPE-SPECIFIC FACTORS].
    RABINOVICH AR
    Probl Gematol Pereliv Krovi; 1964 Jul; 9():38-41. PubMed ID: 14242579
    [No Abstract]   [Full Text] [Related]  

  • 12. The clinical and biological significance of HL-antigen on reticulocytes.
    Zervas JD; Cunliffe D; Delamore IW; Israëls MC
    Br J Haematol; 1971 Sep; 21(3):363. PubMed ID: 5106111
    [No Abstract]   [Full Text] [Related]  

  • 13. [Sensitization caused by rare antigens and hemolytic disease of the newborn].
    Moretti M; Bovi I; Bevilacqua G
    Minerva Pediatr; 1968 Sep; 20(37):1923-5. PubMed ID: 5754687
    [No Abstract]   [Full Text] [Related]  

  • 14. [Pathogenesis of ABO hemolytic disease of the newborn. Critical study].
    Lewi S
    Transfusion (Paris); 1966; 9(3):265-80. PubMed ID: 5969561
    [No Abstract]   [Full Text] [Related]  

  • 15. [Fetal-maternal leakage as 1 of the causes of the pathogenesis of hemolytic disease in the newborn].
    Dziekan L
    Przegl Lek; 1971; 27(2):196-9. PubMed ID: 4994371
    [No Abstract]   [Full Text] [Related]  

  • 16. [Immunologic relations between mother and fetus].
    Delecour M; Monnier JC
    Lille Med; 1968 Nov; 13(9):1021-8. PubMed ID: 4984921
    [No Abstract]   [Full Text] [Related]  

  • 17. [Rh and fetal erythroblastosis].
    Seixas AS; Plepis Júnior M; Werneck PS
    Hospital (Rio J); 1968 Jul; 74(1):207-12. PubMed ID: 4976965
    [No Abstract]   [Full Text] [Related]  

  • 18. Therapeutic abortion as a possible source of Rh immunization.
    Hollán SR; Szelényi JG; Sötér VN; Hasitz M
    Acta Med Acad Sci Hung; 1970; 27(3):337-40. PubMed ID: 4995192
    [No Abstract]   [Full Text] [Related]  

  • 19. [Immune-prevention of fetal erythroblastosis].
    Schubert W
    Z Arztl Fortbild (Jena); 1971 Jun; 65(11):540-5. PubMed ID: 4998879
    [No Abstract]   [Full Text] [Related]  

  • 20. [Hemolytic disease of the newborn due to Kell sensitization].
    Beller U; Hochner-Celnikier D; Ron M; Palti Z; Beyth Y
    Harefuah; 1981 Jul; 101(1-2):14-5. PubMed ID: 7319365
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.